• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Fracture (1260); Failure to Advance (2524); Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/09/2023
Event Type  Injury  
Event Description
It was reported that the device partially deployed, became unraveled and then detached, requiring an additional device.This 7x150, 130 cm eluvia drug-eluting vascular stent system was selected for use in a left popliteal and superficial femoral artery stent procedure.Using a contralateral approach, the 100% stenosed, severely tortuous, severely calcified popliteal and distal sfa lesions were pre-dilated with balloon angioplasty.The stenosis after pre-dilation was 60%.Then resistance was noted when crossing the occlusion to the popliteal lesion with this eluvia stent.The stent was deployed using the thumb wheel; however, only 2 cm of the stent was deployed before a popping sound was heard.The pull grip was also used to attempt deployment.Then the device handle was opened to deploy the stent manually without success.An attempt was made to remove the stent and device and upon doing so, the 2cm section of deployed stent became unraveled and detached from the device.Another stent was implanted inside the same area.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18231456
MDR Text Key329314648
Report Number2124215-2023-64107
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876748
UDI-Public08714729876748
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0030910808
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/16/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexFemale
-
-